Loading clinical trials...

Home Telemonitoring In Patients After Myocardial Infarction | Clinical Trials | Clareo Health

COMPLETEDNA

Home Telemonitoring In Patients After Myocardial Infarction

Home Telemonitoring In Patients After Myocardial Infarction, HELP ME Trial

NCT04664881•Mayo Clinic

Summary

This study is being done to determine if taking an electrocardiogram (ECG) by a portable device (SmartHeart) followed by a phone call will improve patient outcomes by early recognition of abnormalities and decrease emergency room visits and hospital readmissions compared to standard therapy alone.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Acute myocardial infarction, both STEMI and non-STEMI.
•Able to use the home ECG telemonitoring.
•Must have smartphone device with home wi-fi/mobile internet which allows for 24/7 ability to transmit ECG.
•Caring family member who will be able to help/perform the ECG in case the patient won't be able to do it.

Exclusion Criteria

•No ability to use the device at home/unable to comply with the device instructions
•No smartphone device or home wi-fi/mobile internet which prevent 24/7 ability to transmit ECG
•Cannot download the smartheart app
•No support in home environment
•Out of hospital cardiac arrest: secondary to a non-shockable rhythm, unrelated to an acute coronary syndrome, or with any level of neurologic damage.
•Resident of nursing home or acute care facility
•Uninterpretable ECG at discharge - left bundle branch block (LBBB), pacemaker or implantable cardioverter defibrillator (ICD) with pacing dependence.
•Patients who are planned for staged PCI after the index hospitalization

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

October 14, 2020

Primary Completion Date

May 2, 2024

Completion Date

May 2, 2024

Last Updated

May 11, 2025

Enrollment

195

ACTUAL participants

Conditions

Myocardial InfarctionHeart Attack

Interventions

SmartHeart Device

DEVICE

Fast Discharge After Acute Myocardial Infarction Discharge MI

NCT06744322

Acute Myocardial Infarction (AMI)

View study

RECRUITINGPHASE2

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

NCT05198791

Myocardial Infarction, AcuteMyocardial Infarction With Nonobstructive Coronary Arteries+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 11, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Home Telemonitoring In Patients After Myocardial Infarction

Inclusion Criteria

Exclusion Criteria

Fast Discharge After Acute Myocardial Infarction Discharge MI

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

SuperSaturated Oxygen Comprehensive Observational Registry

Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease